Insight

Aug 10, 2024, 13:45

Katsuaki Maehara: EGFR mutated NSCLC

Katsuaki Maehara, Director of Medical Education Colleagues shared a post on X:

“EGFR mutated NSCLC.

This article is the latest data to analyze the concomitant driver alteration of EGFR mutated NSCLC using NGS.

It is also an important dictionary for selecting effective treatment regimens from the analysis results and for encouraging the development of combination therapies.

For all patients with EGFR mutation-positive disease.”

Source: Katsuaki Maehara/X

Landscape of Concomitant Driver Alterations in Classical EGFR-Mutated Non–Small Cell Lung Cancer.

Authors: Huaying Wang, Lie Lin, Chuqiao Liang, Jiaohui Pang, Jiani C. Yin, Junli Zhang, Yang Shao, Chengming Sun, and Renhua Guo.

Katsuaki Maehara

cancer Chengming Sun Chuqiao Liang EGFR Huaying Wang Jiani C. Yin Jiaohui Pang Junli Zhang Katsuaki Maehara Lie Lin non small cell lung cancer NSCLC OncoDaily Oncology Renhua Guo Yang Shao

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

One Hand Gives, Another Takes? Trump, Musk, Congress and Childhood Cancer Research Funding

Fabrice André has been elected as the President of the ESMO for the term 2025-2026

Special Coverage